Discovery Engine

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist approved by the FDA for chronic weight management in adults and adolescents with obesity...

Saxenda (liraglutide) is a once-daily GLP-1 receptor agonist originally developed for type 2 diabetes but later approved for chronic weight management...

Rybelsus is the first oral formulation of semaglutide, FDA-approved for type 2 diabetes management. While not officially indicated for weight loss, it...

Ozempic (semaglutide) is a once-weekly injectable medication from Novo Nordisk, FDA-approved for type 2 diabetes management. By mimicking the GLP-1 ho...

I'm ecstatic that means I have officially lost 7 lbs while being on semaglutide and I'm closer to being in the 200s which I never thought I'd be happy...

Glucagon-like peptide-1 receptor agonists (GLP-1 drugs) have emerged as one of the most significant advances in modern medicine, reshaping how clinici...

In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 drugs) have gained widespread recognition for their ability to manage type 2 diabete...

At a GlanceBoth Wegovy and Ozempic share the same active ingredient: semaglutide.Wegovy is FDA-approved for weight loss, while Ozempic is approved for...